Peri-procedural myocardial injury: 2005 update.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  European Heart Journal

• Publication date

  2005-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/EURHEARTJ/EHI455PMID 16176941
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• “Randomized Trial of High Loading Dose of Clopidogrel for Reduction of Periprocedural Myocardial Infarction in Patients Undergoing Coronary Intervention: Results From the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) Study”

  2005cited by this paper
• Creatine kinase-MB enzyme elevation and long-term clinical events after successful coronary stenting in lesions with ruptured plaque.

  2005cited by this paper
• Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study.

  2005cited by this paper
• Platelet-monocyte aggregates predict troponin rise after percutaneous coronary intervention and are inhibited by Abciximab.

  2005cited by this paper
• Fate of unprotected side branches as related to embolic complications during stent implantation for acute coronary syndromes using a distal protection procedure.

  2005cited by this paper
• Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: a potential role for phosphatase and tensin homolog deleted on chromosome ten?

  2005cited by this paper
• Cardiac myocytes control release of endothelin-1 in coronary vasculature.

  2005cited by this paper
• Antithrombotic therapy during percutaneous coronary intervention

  2005cited by this paper
• The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting.

  2005cited by this paper
• Troponin Elevation After Percutaneous Coronary Intervention Directly Represents the Extent of Irreversible Myocardial Injury: Insights From Cardiovascular Magnetic Resonance Imaging

  2005cited by this paper
• Angiographic, intravascular ultrasound, and fractional flow reserve evaluation of direct stenting vs. conventional stenting using BeStent2 in a multicentre randomized trial.

  2005cited by this paper
• Preprocedural plasma C-reactive protein levels, postprocedural creatine kinase-MB release, and long-term prognosis after successful coronary stenting (four-year results from the GENERATION study).

  2005cited by this paper
• Does pre-treatment with aspirin and loading dose clopidogrel obviate the need for glycoprotein IIb/IIIa antagonists during elective coronary stenting? A focus on peri-procedural myonecrosis.

  2005influential reference
• Randomized Trial of High Loading Dose of Clopidogrel for Reduction of Periprocedural Myocardial Infarction in Patients Undergoing Coronary Intervention: Results From the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) Study*

  2005cited by this paper
• Randomized Trial of Atorvastatin for Reduction of Myocardial Damage During Coronary Intervention: Results From the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) Study

  2004cited by this paper
• Usefulness of periprocedural creatinine phosphokinase-MB release to predict adverse outcomes after intracoronary radiation therapy for in-stent restenosis.

  2004cited by this paper
• Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome.

  2004cited by this paper
• Optimal Windows of Statin Use for Immediate Infarct Limitation : 5

  2004cited by this paper
• Role of apoptosis in reperfusion injury.

  2004cited by this paper
• A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel

  2004cited by this paper
• Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes.

  2004cited by this paper
• Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial.

  2004cited by this paper
• Predictors and prognostic value of myocardial injury following stent implantation.

  2004cited by this paper
• Prognostic Implication of Anemia on In-Hospital Outcomes After Percutaneous Coronary Intervention

  2004cited by this paper
• Glucocorticoid Treatment Prevents Progressive Myocardial Dysfunction Resulting From Experimental Coronary Microembolization

  2004cited by this paper
• Use of statins prior to percutaneous coronary intervention reduces myonecrosis and improves clinical outcome

  2004cited by this paper
• Creatine kinase-myocardial band isoenzyme elevation after percutaneous coronary interventions using sirolimus-eluting stents.

  2004cited by this paper
• Coronary microembolization*1

  2004cited by this paper
• A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel.

  2004cited by this paper
• Early Statin Treatment in Patients With Acute Coronary Syndrome: Demonstration of the Beneficial Effect on Atherosclerotic Lesions by Serial Volumetric Intravascular Ultrasound Analysis During Half a Year After Coronary Event: The ESTABLISH Study

  2004cited by this paper
• Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial).

  2004cited by this paper
• Predictors of troponin elevation after percutaneous coronary intervention.

  2004cited by this paper
• Elevations in Troponin I After Percutaneous Coronary Interventions Are Associated With Abnormal Tissue-Level Perfusion in High-Risk Patients With Non–ST-Segment–Elevation Acute Coronary Syndromes

  2004cited by this paper
• Lack of efficacy of clopidogrel pre-treatment in the prevention of myocardial damage after elective stent implantation.

  2004cited by this paper
• Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment.

  2004cited by this paper
• Embolic Protection With Filtering or Occlusion Balloons During Saphenous Vein Graft Stenting Retrieves Identical Volumes and Sizes of Particulate Debris

  2004cited by this paper
• Percutaneous coronary interventions in Europe 1992-2001.

  2004cited by this paper
• Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein IIb/IIIa blockade compared to heparin with routine glycoprotein IIb/IIIa blockade: a REPLACE-2 substudy.

  2004cited by this paper
• Effects of glycoprotein IIb/IIIa inhibition on microvascular flow after coronary reperfusion. A quantitative myocardial contrast echocardiography study.

  2004cited by this paper
• Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

  2004cited by this paper
• Randomized comparison of direct stenting with predilatation followed by stenting on vessel trauma and restenosis.

  2004cited by this paper
• Too little aspirin for secondary prevention after acute myocardial infarction in patients at high risk for cardiovascular events: Results from the MITRA study.

  2004cited by this paper
• Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventions.

  2004cited by this paper
• Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention.

  2004cited by this paper
• Intracoronary stenting and angiographic results: Restenosis after direct stenting versus stenting with predilation in patients with symptomatic coronary artery disease (ISAR‐DIRECT trial)

  2004influential reference
• Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction.

  2004cited by this paper
• Impact of major side branch on periprocedural enzyme elevation and long-term outcome in patients undergoing percutaneous coronary intervention and brachytherapy for in-stent restenosis.

  2004cited by this paper
• Serotonin blockade protects against early microvascular constriction following atherosclerotic plaque rupture.

  2004cited by this paper
• Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes

  2004cited by this paper
• Distal Protection With a Filter Device During Coronary Stenting in Patients With Stable and Unstable Angina

  2004cited by this paper
• Association between duration of tirofiban therapy before percutaneous intervention and tissue level perfusion (a TACTICS-TIMI 18 substudy).

  2004cited by this paper
• Coronary microembolization.

  2004cited by this paper
• The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty: the ADVANCE Trial.

  2004cited by this paper
• Optimal Windows of Statin Use for Immediate Infarct Limitation: 5′-Nucleotidase as Another Downstream Molecule of Phosphatidylinositol 3-Kinase

  2004cited by this paper
• Long-term effects of quinapril with high affinity for tissue angiotensin-converting enzyme after coronary intervention in Japanese.

  2004cited by this paper
• Relation of Inflammation and Benefit of Statins After Percutaneous Coronary Interventions

  2003cited by this paper
• Postprocedure chest pain after coronary stenting: implications on clinical restenosis.

  2003influential reference
• Randomized Comparison of Distal Protection With a Filter-Based Catheter and a Balloon Occlusion and Aspiration System During Percutaneous Intervention of Diseased Saphenous Vein Aorto-Coronary Bypass Grafts

  2003cited by this paper
• Reduction of myocardial ischemic injury following coronary intervention (the MC-1 to Eliminate Necrosis and Damage trial).

  2003cited by this paper
• Triple antiplatelet therapy during percutaneous coronary intervention is associated withimproved outcomes including one-year survival

  2003cited by this paper
• Direct coronary stent implantation does not reduce the incidence of in-stent restenosis or major adverse cardiac events Six month results of a randomized trial

  2003cited by this paper
• Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET).

  2003cited by this paper
• Comparison of clopidogrel versus ticlopidine for prevention of minor myocardial injury after elective coronary stenting.

  2003cited by this paper
• Preprocedural white blood cell count and death after percutaneous coronary intervention.

  2003cited by this paper
• Comparison of creatine kinase elevation and outcome of comparison of percutaneous coronary intervention for saphenous vein graft in-stent restenosis versus de novo stenosis.

  2003cited by this paper
• Prognostic implication of troponin I elevation after percutaneous coronary intervention.

  2003cited by this paper
• Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway.

  2003cited by this paper
• Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial.

  2003cited by this paper
• Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention.

  2003cited by this paper
• Microparticles in cardiovascular diseases.

  2003cited by this paper
• Effect of percutaneous coronary interventions for in-stent restenosis in degenerated saphenous vein grafts without distal embolic protection.

  2003cited by this paper
• Direct coronary stent implantation does not reduce the incidence of in-stent restenosis or major adverse cardiac events: six month results of a randomized trial.

  2003cited by this paper
• Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement

  2003cited by this paper
• Troponin I elevation and cardiac events after percutaneous coronary intervention.

  2003cited by this paper
• Management of Patients Undergoing Percutaneous Coronary Revascularization

  2003cited by this paper
• Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: results of the Coronary Revascularization Using Integrilin and Single bolus Enoxaparin Study.

  2003cited by this paper
• Prognostic implication of creatine kinase release after elective percutaneous coronary intervention in the pre-IIb/IIIa antagonist era.

  2003cited by this paper
• Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention.

  2003cited by this paper
• The prevention of minor myocardial injury with ticlopidine pretreatment in patients undergoing elective coronary stenting.

  2003cited by this paper
• Distal Myocardial Protection During Percutaneous Coronary Intervention With an Intracoronary &bgr;‐Blocker

  2003influential reference
• Platelet Glycoprotein IIb/IIIa Receptor Blockade Improves Vascular Nitric Oxide Bioavailability in Patients With Coronary Artery Disease

  2003cited by this paper
• Impact of renal function on morbidity and mortality after percutaneous aortocoronary saphenous vein graft intervention.

  2003cited by this paper
• Ischemia Modified Albumin Is a Sensitive Marker of Myocardial Ischemia After Percutaneous Coronary Intervention

  2003influential reference
• Patients at low risk for periprocedural myocardial infarction can be identified by assessment immediately following percutaneous coronary intervention.

  2003cited by this paper
• Immunomediated and Ischemia-Independent Inflammation of Coronary Microvessels in Unstable Angina

  2003cited by this paper
• Society of cardiac angiography and interventions: Suggested management of the no‐reflow phenomenon in the cardiac catheterization laboratory

  2003cited by this paper
• Cytokine response after percutaneous coronary intervention in stable angina: effect of selective glycoprotein IIb/IIIa receptor antagonism.

  2003cited by this paper
• Effect of direct stenting on clinical outcome in patients treated with percutaneous coronary intervention on saphenous vein graft.

  2003cited by this paper
• Ischaemic preconditioning and outcomes after angioplasty: effects of drug therapy.

  2003cited by this paper
• Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention.

  2003cited by this paper
• Comparison of different cardiac markers in monitoring percutaneous coronary interventions with frequent use of stents and gpIIbIIIa-antagonists

  2003cited by this paper
• Stenting of Culprit Lesions in Unstable Angina Leads to a Marked Reduction in Plaque Burden: A Major Role of Plaque Embolization?: A Serial Intravascular Ultrasound Study

  2003cited by this paper
• Direct stenting may limit myocardial injury during percutaneous coronary intervention.

  2003cited by this paper
• Multicenter randomized comparison of direct vs. conventional stenting: The DIRECTO trial

  2003cited by this paper
• Coronary Flow Velocity Reserve After Percutaneous Interventions Is Predictive of Periprocedural Outcome

  2002cited by this paper
• Prognostic implication of cardiac troponin T increase following stent implantation

  2002cited by this paper
• Association of systemic inflammatory state with troponin I elevation after elective uncomplicated percutaneous coronary intervention.

  2002influential reference
• Long-term efficacy of platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention.

  2002cited by this paper
• Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound study.

  2002cited by this paper
• Comparison of long-term survival following non-Q-wave creatine kinase elevation after percutaneous coronary intervention in patients discharged on a beta blocker versus those not so treated.

  2002cited by this paper

• Predictive ability of microvascular resistance reserve for periprocedural myocardial injury in patients with stable coronary artery disease undergoing percutaneous coronary intervention.

  2025cites this paper
• Intraoperative hemodynamic imbalance quantification: clinical validation of heart rate to mean blood pressure ratio in predicting myocardial injury after noncardiac surgery

  2025cites this paper
• Perioperative Myocardial Injury/Infarction in Patients with Stable or Unstable Angina Pectoris Undergoing Elective Percutaneous Coronary Intervention: The Effects of Preoperative Lipid Management

  2025cites this paper
• Cardioprotection method for percutaneous coronary interventions in elderly patients with acute coronary syndrome

  2025cites this paper
• Myocardial injury following elective percutaneous coronary interventions: prevalence, risk factors and prognostic significance

  2025cites this paper
• Interaction between coronary lesion complexity and coronary microvascular dysfunction in the prognosis of NSTEMI patients.

  2025cites this paper
• Current Challenges in Coronary Bifurcation Interventions

  2024cites this paper
• Intracoronary administration of tenecteplase to prevent PCI-related myocardial infarction in patients with echo-attenuated coronary plaques: study protocol for a multicenter, prospective, randomized controlled trial

  2024cites this paper
• Identification of potential therapeutic targets from bioinformatics analysis of necroptosis and immune infiltration in acute myocardial infarction

  2024cites this paper
• Evaluation of microcirculatory protection in percutaneous revascularisation: A stent implantation technique and device comparison

  2024cites this paper
• Short- and long-term outcomes of antegrade versus retrograde approaches in patients undergoing percutaneous coronary intervention for chronic total occlusion: A meta-analysis.

  2024cites this paper
• The immunopathology of coronary microembolization and the underlying inflammopathophysiological mechanisms.

  2024cites this paper
• Periprocedural myocardial injury after elective percutaneous coronary intervention in stable angina pectoris: a tertiary center experience

  2023cites this paper
• Abnormal release of cardiac biomarkers in the presence of myocardial edema evaluated by cardiac magnetic resonance after uncomplicated revascularization procedures.

  2023cites this paper
• Prognostic Impact of Periprocedural Myocardial Infarction in Patients with Heavily Calcified Coronary Artery Disease Receiving Rotational Atherectomy

  2023cites this paper
• Any Target Value of LDL-cholesterol before Elective PCI? A study at NICVD on Association of LDL-Cholesterol levels with Myocardial Injury during Elective PCI

  2023cites this paper
• Mechanical Support Strategies for High-Risk Procedures in the Invasive Cardiac Catheterization Laboratory: A State-of-the-Art Review

  2023cites this paper
• Activities of daily living predict periprocedural myocardial infarction and injury following percutaneous coronary intervention: a cross-sectional study

  2023influential citation
• Prognostic Impact of Atrial Fibrillation in Patients with Heavily Calcified Coronary Artery Disease Receiving Rotational Atherectomy

  2023cites this paper
• Interventions in chronic total occlusions with bifurcation lesions: incidence, treatment, and in-hospital outcome.

  2023cites this paper
• Diagnostic and treatment value of XPNPEP3 in acute myocardial infarction

  2023cites this paper
• Association of serum laboratory parameters with periprocedural myocardial infarction after a primary percutaneous coronary intervention

  2022cites this paper
• A Randomized, Placebo-controlled, Double-blind Trial to Evaluate Efficacy and Safety of Shen-Yuan-Dan Capsules, A Traditional Chinese Medicine, for Treatment of Peri-procedure Myocardial Injury Following Percutaneous Coronary Intervention.

  2022cites this paper
• Prediction Of No Reflow Using Syntax II Score in Patients of Acute ST Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

  2022cites this paper
• Rosuvastatin Alleviates Coronary Microembolization-Induced Cardiac Injury by Suppressing Nox2-Induced ROS Overproduction and Myocardial Apoptosis

  2022cites this paper
• The effectiveness and safety of acupuncture kinesitherapy after percutaneous coronary intervention in patients with coronary heart disease: study protocol for a randomized controlled trial

  2022cites this paper
• Prognostic Role of Cardiac Troponin I after Percutaneous Coronary Intervention in Stable Coronary Disease

  2022cites this paper
• Efficacy of Shexiang Tongxin Dropping Pills in a Swine Model of Coronary Slow Flow

  2022influential citation
• Association Between Contrast Volume-to-Creatinine Clearance Ratio and the Risk of Perioperative Myocardial Infarction After Elective Percutaneous Coronary Intervention.

  2022cites this paper
• Effects of bilirubin on perioperative myocardial infarction and its long-term prognosis in patients undergoing percutaneous coronary intervention

  2022cites this paper
• Predictors and clinical significance of periprocedural myocardial infarction following rotational atherectomy

  2022cites this paper
• Coenzyme Q10 Reduces Infarct Size in Animal Models of Myocardial Ischemia-Reperfusion Injury: A Meta-Analysis and Summary of Underlying Mechanisms

  2022cites this paper
• Gensini score values for predicting periprocedural myocardial infarction: An observational study analysis

  2022influential citation
• Prognostic role of hs-CRP before and after Percutaneous Coronary Intervention in Patients with Stable Angina Pectoris

  2022cites this paper
• A fresh look at coronary microembolization

  2021cites this paper
• Metallothionein-2A protect Cardiomyocytes from Ischemia/Reperfusion through inhibiting p38

  2021cites this paper
• Colchicine for the Prevention of Myocardial Injury Following Elective PCI: A Randomized Clinical Trial

  2021cites this paper
• Association between the magnitude of periprocedural myocardial injury and prognosis in patients undergoing elective percutaneous coronary intervention

  2021cites this paper
• Utility of near‐infrared spectroscopy to detect the extent of lipid core plaque leading to periprocedural myocardial infarction

  2021cites this paper
• Myocardial preservation during primary percutaneous intervention: It's time to rethink?

  2021cites this paper
• Inflammation during Percutaneous Coronary Intervention—Prognostic Value, Mechanisms and Therapeutic Targets

  2021cites this paper
• Association of peri‐procedural myocardial infarction with mortality after stenting true coronary bifurcation lesions: A pooled individual participant data analysis from four randomized controlled trials

  2021influential citation
• Peripheral Artery Tonometry Reveals Impaired Endothelial Function before Percutaneous Coronary Intervention in Patients with Periprocedural Myocardial Injury

  2021cites this paper
• Efficacy of Trimetazidine in Limiting Periprocedural Myocardial Injury in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis

  2021cites this paper
• High-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in East Asian patients undergoing percutaneous coronary intervention

  2021influential citation
• Prognostic Impact of Percutaneous Coronary Intervention of Chronic Total Occlusion in Acute and Periprocedural Myocardial Infarction

  2021cites this paper
• Prognosis of spontaneous myocardial infarction and various definitions of periprocedural myocardial infarction in patients who underwent percutaneous coronary intervention.

  2021cites this paper
• Impact of coronary stenting on top of medical therapy and of inclusion of periprocedural infarctions on hard composite endpoints in patients with chronic coronary syndromes: a meta-analysis of randomized controlled trials.

  2021cites this paper
• Identification of important genes related to ferroptosis and hypoxia in acute myocardial infarction based on WGCNA

  2021cites this paper
• Comparison of the incidence of periprocedural myocardial infarction between percutaneous coronary intervention with versus without rotational atherectomy using propensity score-matching

  2021cites this paper
• Association of major adverse cardiovascular events and cardiac troponin-I levels following percutaneous coronary intervention: a three-year follow-up study at a single center.

  2020cites this paper
• Myocardial damage associated with elective percutaneous coronary intervention in Chinese patients: a retrospective study

  2020cites this paper
• DDDT_A_272877 4407..4422

  2020cites this paper
• Gambaran Faktor Risiko Periprocedural Myocardial Injury pada Pasien yang Menjalani

  2020cites this paper
• Incidence, predictors and clinical significance of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.

  2020cites this paper
• Association between serum angiopoietin-2 concentrations and periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention

  2020cites this paper
• Six months follow-up of protected high-risk percutaneous coronary intervention with the microaxial Impella pump: results from the German Impella registry

  2020cites this paper
• The Effect of Atorvastatin Administration before Percutaneous Coronary Intervention on Stable Coronary Artery Disease Against Event of Periprocedural Myocardial Infarction

  2020cites this paper
• Impact of the Polymorphism rs5751876 of the Purinergic Receptor ADORA2A on Periprocedural Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention

  2020cites this paper
• Determinants of Periprocedural Myocardial Infarction in Current Elective Percutaneous Coronary Interventions.

  2020cites this paper
• A machine learning-based approach for the prediction of periprocedural myocardial infarction by using routine data.

  2020cites this paper
• Für Sie gelesen: Effect of Trimetazidine in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis

  2020cites this paper
• POST PCI MYOCARDIAL INFARCTION A SILENT KILLER FACT OR FICTION. DOES IT REALLY EXIST? WHERE DO WE STAND?

  2020cites this paper
• Relationship of lipoprotein-associated phospholipase A2(Lp-PLA2) and periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention

  2020cites this paper
• The prognostic significance of periprocedural infarction in the era of potent antithrombotic therapy. The PRAGUE-18 substudy.

  2020cites this paper
• Alprostadil Injection Attenuates Coronary Microembolization-Induced Myocardial Injury Through GSK-3β/Nrf2/HO-1 Signaling-Mediated Apoptosis Inhibition

  2020cites this paper
• Effects of statin pretreatment on adverse cardiac events following elective percutaneous coronary intervention

  2020cites this paper
• Periprocedural myocardial and renal injury in patients undergoing elective percutaneous coronary interventions – is there an association?

  2019cites this paper
• Lipid-Core Plaque Assessed by Near-Infrared Spectroscopy and Procedure Related Microvascular Injury

  2019cites this paper
• Effectiveness of resistance interval training versus aerobic interval training on peak oxygen uptake in patients with myocardial infarction.

  2019cites this paper
• FREQUENCY AND CAUSES OF PERIPROCEDURAL MYOCARDIAL INFARCTION IN COMPLEX CORONARY INTERVENTIONS

  2019cites this paper
• Pyrrolidine Dithiocarbamate Attenuates Cardiocyte Apoptosis and Ameliorates Heart Failure Following Coronary Microembolization in Rats

  2019cites this paper
• Comparison of the effect of 80 vs 40 mg atorvastatin in patients with isolated coronary artery bypass graft surgery: A randomized clinical trial

  2019influential citation
• ETUDE DES FACTEURS PREDICTIFS DE L’ATTEINTE DE LA MICROCIRCULATION CORONAIRE INDUITE PAR ANGIOPLASTIE ELECTIVE, MESUREE PAR L’INDEX OF MICROCIRCULATORY RESISTANCE (IMR), CHEZ DES PATIENTS SOUFFRANT D’ANGOR STABLE.

  2019cites this paper
• Anti-inflammatory therapy during percutaneous coronary intervention

  2019cites this paper
• Neutrophil count as the centerpiece in the joined association networks of inflammatory and cell damage markers, and neuroendocrine stress markers in patients with stable angina pectoris following stenting

  2019cites this paper
• Efficacy and safety of Shen-Yuan-Dan capsules for peri-procedural myocardial injury following percutaneous coronary intervention: study protocol for a randomized, double-blind, placebo-controlled trial.

  2019cites this paper
• Identification of patients at higher risk for myocardial injury following elective coronary artery intervention

  2019cites this paper
• Association between changes in platelet reactivity during elective percutaneous coronary intervention and periprocedural myocardial infarction: A pilot study.

  2019cites this paper
• Periprocedural myocardial infarction and injury in elective coronary stenting

  2018cites this paper
• Impact of paclitaxel-coated balloon versus newer-generation drug-eluting stent on periprocedural myocardial infarction in stable angina patients

  2018cites this paper
• Unprotected versus protected high-risk percutaneous coronary intervention with the Impella 2.5 in patients with multivessel disease and severely reduced left ventricular function

  2018cites this paper
• Optical Coherence Tomography-Defined Plaque Vulnerability in Relation to Functional Stenosis Severity and Microvascular Dysfunction.

  2018cites this paper
• Peri-procedural myocardial infarction is all the same?

  2018influential citation
• Role of metabolic manipulator trimetazidine in limiting percutaneous coronary intervention–induced myocardial injury

  2018cites this paper
• Impact of pre-procedural dual antiplatelet therapy on periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions with adjunctive tirofiban.

  2018cites this paper
• Risks and Complications of Coronary Angiography and Other Percutaneous Intervention: A Comprehensive Review with Data of Single High Volume Center

  2018cites this paper
• MYOCARDIAL REPERFUSION IN PATIENTS WITH ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN THE USE OF MANUAL THROMBUS ASPIRATION

  2018cites this paper
• Effect of Remote Ischemic Preconditioning on the Periprocedural Myocardial Injury Events during Elective Percutaneous Coronary Intervention

  2018cites this paper
• Atherosclerotic Plaque Component as a Risk Factor for Distal Embolization During Percutaneous Coronary Intervention　- Pathology of Tissue Obtained by Distal Protection Device.

  2018cites this paper
• Coronary microembolization and microvascular dysfunction.

  2018cites this paper
• The Risk Factors of Myocardial Infraction after Aortic Valve Replacement: A Systematic Review and Meta-Analysis

  2018cites this paper
• The impact of a single episode of remote ischemic preconditioning on myocardial injury after elective percutaneous coronary intervention

  2017cites this paper
• Coenzyme Q10 Regulates Antioxidative Stress and Autophagy in Acute Myocardial Ischemia-Reperfusion Injury

  2017cites this paper
• Plasma apelin-12 levels may predict in-hospital major adverse cardiac events in ST-elevation myocardial infarction and the relationship between apelin-12 and the neutrophil/lymphocyte ratio in patients undergoing primary coronary intervention

  2017cites this paper
• Periprocedural Myocardial Injury Depends on Transcatheter Heart Valve Type But Does Not Predict Mortality in Patients After Transcatheter Aortic Valve Replacement.

  2017cites this paper
• Association between plaque characteristics and the amount of debris captured by a filter-type distal protection device in patients with acute coronary syndrome.

  2017cites this paper
• TREATMENT OF TISSUE VAAPPLICATION OF MAGNETIC FELD

  2017cites this paper
• Periprocedural myocardial infarction during percutaneous coronary intervention in an academic tertiary centre in Johannesburg.

  2017cites this paper
• Effects of remote ischemic preconditioning on myocardial injury and endothelial function and prognosis after percutaneous coronary intervention in patients with acute coronary syndrome.

  2017cites this paper